Back to the list
close
Journal
Nature Biotechnology
Citation weight
TierA
Weight in force1×
Weightingoff
Weight inputs
Each figure with its percentile among the ranked journals. A is the median, over the academics with a work here, of that academic’s citations to the works this site counts for them - never a Google Scholar profile total. Over every academic of this field, all years, whatever the filters select.
A · academics’ median15,475.0 · 73%
B · citations per work742.9 · 98%
N · works48 · 46%
P · academics11 · 19%
Formula result1.232
From this institution
Under these filters. A work with no citation count is unknown here, never a zero.
Works48
Citations21,545 over 29 of 48 works
Citations per counted work742.9
Weighted citations—
Academics11
Departments6
First seen1994
Works placed per year
48 of these 48 works carry a year; an undated work is in no year. Works placed, under these filters.
Departments publishing there 6
| Department | Works |
|---|---|
| Harvard Chemistry | 38 |
| Yale Chemistry | 4 |
| Princeton Chemistry | 3 |
| Columbia Chemistry | 1 |
| Cornell Chemistry | 1 |
| Penn Chemistry | 1 |
A work held by two departments counts once in each, so these add up to more than the works above.
Works placed there 48
| Year | Title | Academics | Citations |
|---|---|---|---|
| 2020 | Genome Editing with CRISPR-Cas Nucleases, Base Editors, Transposases, and Prime Editors | David R. Liu | 2,769 |
| 2013 | High-Throughput Profiling of Off-Target DNA Cleavage Reveals RNA-Programmed Cas9 Nuclease Specificity | David R. Liu | 2,121 |
| 2019 | CRISPResso2 provides accurate and rapid genome editing sequence analysis | David R. Liu | 1,940 |
| 2015 | Cationic Lipid-Mediated Delivery of Proteins Enables Efficient Protein-Based Genome Editing In Vitro and In Vivo | David R. Liu | 1,862 |
| 2014 | Fusion of Catalytically Inactive Cas9 to FokI Nuclease Improves the Specificity of Genome Modification | David R. Liu | 1,276 |
| 2020 | Phage-Assisted Evolution of an Adenine Base Editor with Enhanced Cas Domain Compatibility and Activity | David R. Liu | 1,274 |
| 2018 | Improving Cytidine and Adenine Base Editors by Expression Optimization and Ancestral Reconstruction | David R. Liu | 1,169 |
| 2017 | Increasing the Genome-Targeting Scope and Precision of Base Editing with Engineered Cas9-Cytidine Deaminase Fusions | David R. Liu | 1,052 |
| 2020 | Prime Genome Editing in Rice and Wheat | David R. Liu | 1,037 |
| 2022 | Engineered pegRNAs Improve Prime Editing Efficiency | David R. Liu | 890 |
| 2008 | Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy | Joshua Rabinowitz | 777 |
| 2022 | Programmable Deletion, Replacement, Integration, and Inversion of Large DNA Sequences with Twin Prime Editing | David R. Liu | 756 |
| 2020 | Evaluation and Minimization of Cas9-Independent Off-Target DNA Editing by Cytosine Base Editors | David R. Liu | 587 |
| 2014 | Enzyme clustering accelerates processing of intermediates through metabolic channeling | Joshua Rabinowitz | 528 |
| 2007 | Redirecting lipoic acid ligase for cell surface protein labeling with small-molecule probes | Jeremy M. Baskin | 480 |
| 2020 | Continuous Evolution of SpCas9 Variants Compatible with Non-G PAMs | David R. Liu | 470 |
| 2019 | Continuous Evolution of Base Editors with Expanded Target Compatibility and Improved Activity | David R. Liu | 459 |
| 1994 | Recombinant Proteins Can Be Released From E. Coli Cells By Repeated Cycles of Freezing and Thawing | Michael Hecht | 390 |
| 2020 | Programmable m6A Modification of Cellular RNA with a Cas13-Directed Methyltransferase | David R. Liu | 363 |
| 2000 | Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin | Jon Ellman | 355 |
| 2019 | Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editors | David R. Liu | 351 |
| 2025 | Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR–Cas9 ribonucleoprotein | Kai Chen | 217 |
| 2022 | Prediction of protein–ligand binding affinity from sequencing data with interpretable machine learning | Neel H. Shah | 143 |
| 2023 | Design of a mucin-selective protease for targeted degradation of cancer-associated mucins | Stacy Malaker | 94 |
| 2023 | Time-tagged ticker tapes for intracellular recordings | Adam Cohen | 64 |
| 2023 | Massively parallel knock-in engineering of human T cells | Sarah Slavoff | 57 |
| 2011 | New fluorescent probes for super-resolution imaging | Xiaowei Zhuang | 39 |
| 2012 | Discovering ligand-receptor interactions | Sarah Slavoff | 22 |
| 2026 | AI-guided Re-design of Laboratory-Evolved Reverse Transcriptases Enhances Prime Editing in Human Cells and in Animals | David R. Liu | 3 |
| 2024 | Efficient Prime Editing in Mouse Brain, Liver and Heart with Dual AAVs | David R. Liu | — |
| 2026 | Mechanistic Machine Learning for Prediction of Prime Editing Outcomes | David R. Liu | — |
| 2026 | Evolution of Botulinum Neurotoxin Serotype X Proteases to Induce Inflammatory Cell Death in Cancer Cells | David R. Liu | — |
| 2025 | Branched, Chemically Modified Poly(A) Tails Enhance the Translation Capacity of mRNA | David R. Liu | — |
| 2023 | High-Throughput Continuous Evolution of Compact Cas9 Variants Targeting Single-Nucleotide-Pyrimidine PAMs | David R. Liu | — |
| 2024 | Adenine Transversion Editors Enable Precise, Efficient A•T-To-C•G Base Editing in Mammalian Cells and Embryos | David R. Liu | — |
| 2021 | Efficient C•G-to-G•C Base Editors Developed Using CRISPRi Screens, Target-Library Analysis and Machine Learning | David R. Liu | — |
| 2002 | Nucleic Acid Evolution and Minimization by Nonhomologous Random Recombination | David R. Liu | — |
| 2025 | Directed Evolution of Engineered Virus-Like Particles with Improved Production and Transduction Efficiencies | David R. Liu | — |
| 2026 | Directed Evolution of Small RNA-Stabilizing Motifs that Improve Prime Editing | David R. Liu | — |
| 2023 | Evolution of an Adenine Base Editor into a Small, Efficient Cytosine Base Editor with Low Off-Target Activity | David R. Liu | — |
| 2024 | Engineered Virus-Like Particles for Transient Delivery of Prime Editor Ribonucleoprotein Complexes In Vivo | David R. Liu | — |
| 2025 | High Throughput Evaluation of Genetic Variants with Prime Editing Sensor Libraries | David R. Liu | — |
| 2024 | Efficient Prime Editing in Two-Cell Mouse Embryos Using PEmbryo | David R. Liu | — |
| 2022 | CRISPR-Free Base Editors with Enhanced Activity and Expanded Targeting Scope in Mitochondrial and Nuclear DNA | David R. Liu | — |
| 2026 | Virus-like Particles Enable Targeted Gene Engineering and Pooled CRISPR Screening in Primary Human Myeloid Cells | David R. Liu | — |
| 2019 | CRISPResso2: Accurate and Rapid Analysis of Genome Editing Data from Nucleases and Base Editors | David R. Liu | — |
| 2024 | A Prime Editor Mouse to Model a Broad Spectrum of Somatic Mutations In Vivo | David R. Liu | — |
| 2019 | Circularly Permuted and Modified-PAM Base Editors with Diversified Targeting Scope | David R. Liu | — |
Citations as counted, before any journal weight: 29 of these 48 works carry a count, and a work with no count is unknown, never a zero.